Lewis C. Cantley and Kristy Richards are growing radically collaborative research connections between Weill Cornell Medicine and the College of Veterinary Medicine.
To better understand, prevent and treat diseases passed from insects to people, the Cornell-led Northeast Regional Center for Excellence in Vector Borne Diseases will launch later this month.
Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
A Cornell research group reports that a mechanical factor - stiffening of a cancer cell and its matrix - and not a chemical cause could contribute to metastasis in some forms of cancer.
The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.
Scientists from Weill Cornell Medicine discovered an internal code in cellular molecules, called messenger RNA, predetermines how much protein they will produce.
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.
Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
